Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

Wellcome Trust Sanger Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Wellcome Trust Sanger Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Wellcome Trust Sanger Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Wellcome Trust Sanger Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research and the clinical applications of genomics in human and infectious disease. Sanger Institute works in collaboration with academic, industrial, biotech and pharmaceutical industries for national and international projects. It is funded by Wellcome Trust, UK Research Councils, Charities, the EU and NIH. The institute has facilities for protein mass spectrometry, fluorescence activated cell sorting and cytogenetics and single cell genomics. Sanger Institute is headquartered in Hinxton, the UK.

Wellcome Trust Sanger Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Wellcome Trust Sanger Institute, Medical Devices Deals, 2012 to YTD 2018 10

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Sigma-Aldrich Enters into Agreement with Sanger Institute 12

AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 13

Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 14

Licensing Agreements 15

Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 15

Equity Offering 16

Microbiotica Spin Off from Wellcome Trust Sanger Institute 16

Wellcome Trust Sanger Institute-Key Competitors 17

Wellcome Trust Sanger Institute-Key Employees 18

Wellcome Trust Sanger Institute-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Government and Public Interest 20

Sep 12, 2018: Study links common arthritis drug azathioprine to skin cancer 20

Sep 03, 2018: Regulator protein key to malaria parasite's lifecycle 21

Aug 09, 2018: Human Cell Atlas gets a boost with first funding from Wellcome 22

Jul 16, 2018: New study finds CRISPR/Cas9 gene editing causes greater DNA damage 24

Jun 18, 2018: Genomics offers new treatment options for infants with range of soft tissue tumours 25

Jun 12, 2018: Genetic discovery will help clinicians identify aggressive versus benign bone tumours 26

May 03, 2018: Deadliest human malaria parasite reveals the genomic chinks in its armour 27

May 02, 2018: Worm experiments offer new insight into mutational causes of cancer 28

Apr 11, 2018: Single cell technology and organoids reveal every bowel tumour and bowel cancer cell have unique genetic fingerprints 30

Mar 20, 2018: Switch discovered to convert blood vessels to blood stem cells during embryonic development 31

Mar 19, 2018: New osteoarthritis genes discovered 32

Feb 20, 2018: Typhoid outbreak: genetic cause of extensive drug resistance found 34

Dec 08, 2017: GBP3.9m project to support elimination of the world's leading infectious cause of blindness 35

Nov 27, 2017: Unforseen new drug target discovered for acute myeloid leukaemia 37

Oct 23, 2017: Five new malaria targets that could lead to an effective vaccine 38

Oct 11, 2017: New type of stem cell line produced offers expanded potential for research and treatments 39

Sep 13, 2017: Immunotherapy treatment option for selected breast cancer patients, genetic study suggests 41

Sep 07, 2017: The Brain Tumour Charity grants WINDOW Consortium GBP1.5 million for new research into combination therapies to treat brain cancer 42

Jul 13, 2017: Largest study of malaria gene function reveals many potential drug targets 43

Mar 23, 2017: New stem cell method produces millions of human brain and muscle cells in days 44

Mar 03, 2017: Latest genomic technology uncovers secrets of immune system's response to malaria 45

Feb 10, 2017: Malaria vaccine target's invasion partner uncovered 46

Product News 47

Oct 19, 2017: Thermo Fisher Scientific and Wellcome Trust Sanger Institute Announce the Axiom Africa Array for Medical and Population Genomics 47

May 08, 2018: Machine learning flags emerging pathogens 48

Other Significant Developments 49

Oct 26, 2018: Cancer Gene Census to help improve personalised medicine 49

Jun 06, 2018: Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria 50

Nov 09, 2017: Australia joins world-first Human Cell Atlas effort 51

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Wellcome Trust Sanger Institute, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Key Facts 2

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Wellcome Trust Sanger Institute, Deals By Therapy Area, 2012 to YTD 2018 9

Wellcome Trust Sanger Institute, Medical Devices Deals, 2012 to YTD 2018 10

Wellcome Trust Sanger Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Sigma-Aldrich Enters into Agreement with Sanger Institute 12

AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 13

Blueprint Medicines Enters Into Co-Development Agreement With Wellcome Trust Sanger Institute And Massachusetts General Hospital Cancer Center 14

Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 15

Microbiotica Spin Off from Wellcome Trust Sanger Institute 16

Wellcome Trust Sanger Institute, Key Competitors 17

Wellcome Trust Sanger Institute, Key Employees 18

Wellcome Trust Sanger Institute, Other Locations 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Wellcome Trust Sanger Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person